Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6. (Q53829100)

20 May 2018

title

Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6. (English)

1 reference

20 May 2018

main subject

multiple drug resistance

1 reference

Hua Sun

1 reference

20 May 2018

Xiao-Dong Liu

1 reference

20 May 2018

Qian Liu

1 reference

20 May 2018

Feng-Peng Wang

1 reference

20 May 2018

Xiu-Qi Bao

1 reference

20 May 2018

Dan Zhang

1 reference

20 May 2018

publication date

1 January 2015

1 reference

20 May 2018

Journal of Asian Natural Products Research

published in

1 reference

20 May 2018

volume

1 reference

20 May 2018

issue

1 reference

20 May 2018

page(s)

638-648

1 reference

20 May 2018

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Multiple molecular mechanisms for multidrug resistance transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

Mechanism-based cancer therapy: resistance to therapy, therapy for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020.2015.1047772

10.1080/10286020.2015.1047772

21 January 2018

Identifiers

DOI

1 reference

20 May 2018

1 reference

20 May 2018